During the most recent trading session, shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) changed +5.05%. Street analysts that track the company are anticipating the stock to go to $436.73 within the next year. Target price projections may vary greatly depending on the specific analyst providing data. This consensus target is compiled using analysts polled by Thomson Reuters.
Sell-side analysts are able to use multiple metrics in order to help calculate target price estimates. A widely used metric is a company’s preice to earnings ratio. This calculation is derived from dividing the current share price by the projected earnings per share. Regeneron Pharmaceuticals, Inc. currently has a P/E Ratio of 54.39. Investors might also evaluate a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio under one, it may be seen as undervalued. If a company has a PEG Ratio over one, it may represent that the company is overvalued. A PEG Ratio near one may be viewed as fair value. Currently, the company has a PEG Ratio of 1.58.
Looking at stock performance, company shares have recently traded $-6.63 away from the 50-day moving average of $379.63 and $-14.73 away from the 200-day moving average of $387.73. The stock has been recently noted -27.05% off of the 52-week high of 511.31 and +14.65% off of the 52-week low of 325.35. Monitoring the stock price relative to moving averages and highs and lows for the year may help evaluate the value of the stock in the future.